@misc{indiciae0f443903e6df,
  title = {Durability and Safety of Imeglimin as an Add-On to DPP-4 Inhibitors in Japanese Type 2 Diabetes: The 104-Week FAMILIAR Trial.},
  author = {Masashi Shimoda and Takeshi Osonoi and Masahiro Iwamoto and Hideaki Kaneto and Kohei Kaku},
  year = {2026},
  doi = {10.1111/dom.71079},
  url = {https://pubmed.ncbi.nlm.nih.gov/42473296/},
  note = {Source identifier: 42473296}
}